The level of galectin-3 in the blood serum of patients with chronic hepatitis C

Aim. to assess galectin-3 level in the serum of HCV patients according to the biochemical activity of hepatitis, liver fibrosis, in view of insulin resistance and overweight.Materials and methods: The content of serum galectin-3 was detected in 78 patients with chronic hepatitis C in age from 20 to...

Full description

Bibliographic Details
Main Authors: V. A. Kovalevа, N. S. Zhevnerova, T. V. Antonova
Format: Article
Language:Russian
Published: Journal Infectology 2016-07-01
Series:Журнал инфектологии
Subjects:
Online Access:https://journal.niidi.ru/jofin/article/view/484
_version_ 1826557852137816064
author V. A. Kovalevа
N. S. Zhevnerova
T. V. Antonova
author_facet V. A. Kovalevа
N. S. Zhevnerova
T. V. Antonova
author_sort V. A. Kovalevа
collection DOAJ
description Aim. to assess galectin-3 level in the serum of HCV patients according to the biochemical activity of hepatitis, liver fibrosis, in view of insulin resistance and overweight.Materials and methods: The content of serum galectin-3 was detected in 78 patients with chronic hepatitis C in age from 20 to 55 years with oligosymptomatic course of the disease and minimally expressed liver fibrosis in most cases. We evaluated the association between the content of galectin-3 in the blood and metabolic disorders, biochemical activity of hepatitis and fibrosis of the liver.Results: In patients with normal ALT levels (42% of the patients), the average level of galectin was 3.17 (1.23; 5.94) ng / ml. Elevated levels of gammaglobulin in blood was noted in 21 patients, 15 of them also had elevated levels of galectin-3. Patients infected with genotype 1b, galectin-3 was higher than other genotypes. With a high viral load (> 500,000 IU / mL), the average level of galectin-3 was higher than the lowest. One-third of patients with overweight levels of galectin-3 was higher than normal. MI was diagnosed in the majority (61.5%) examinees, and in these patients, there was an increase level of galectin-3. When comparing the levels of galectin in patients with varying degrees of fibrosis, significant differences were found only when F0 – F2 (p = 0,033).Conclusion: The galectin-3 serum level was elevated in most patients with chronic hepatitis C. The maximum increase in galectin-3 was observed in patients with severe liver fibrosis (F 3). The connection between the level of galectin-3 and the metabolic syndrome components such as body mass index, and insulin resistance was found.
first_indexed 2024-03-12T04:46:12Z
format Article
id doaj.art-a686f705360d4615a19cde7643f929ac
institution Directory Open Access Journal
issn 2072-6732
language Russian
last_indexed 2025-03-14T08:35:10Z
publishDate 2016-07-01
publisher Journal Infectology
record_format Article
series Журнал инфектологии
spelling doaj.art-a686f705360d4615a19cde7643f929ac2025-03-02T13:00:28ZrusJournal InfectologyЖурнал инфектологии2072-67322016-07-01828591481The level of galectin-3 in the blood serum of patients with chronic hepatitis CV. A. Kovalevа0N. S. Zhevnerova1T. V. Antonova2The First Saint-Petersburg State Medical University named after academician I.P. PavlovThe First Saint-Petersburg State Medical University named after academician I.P. PavlovThe First Saint-Petersburg State Medical University named after academician I.P. PavlovAim. to assess galectin-3 level in the serum of HCV patients according to the biochemical activity of hepatitis, liver fibrosis, in view of insulin resistance and overweight.Materials and methods: The content of serum galectin-3 was detected in 78 patients with chronic hepatitis C in age from 20 to 55 years with oligosymptomatic course of the disease and minimally expressed liver fibrosis in most cases. We evaluated the association between the content of galectin-3 in the blood and metabolic disorders, biochemical activity of hepatitis and fibrosis of the liver.Results: In patients with normal ALT levels (42% of the patients), the average level of galectin was 3.17 (1.23; 5.94) ng / ml. Elevated levels of gammaglobulin in blood was noted in 21 patients, 15 of them also had elevated levels of galectin-3. Patients infected with genotype 1b, galectin-3 was higher than other genotypes. With a high viral load (> 500,000 IU / mL), the average level of galectin-3 was higher than the lowest. One-third of patients with overweight levels of galectin-3 was higher than normal. MI was diagnosed in the majority (61.5%) examinees, and in these patients, there was an increase level of galectin-3. When comparing the levels of galectin in patients with varying degrees of fibrosis, significant differences were found only when F0 – F2 (p = 0,033).Conclusion: The galectin-3 serum level was elevated in most patients with chronic hepatitis C. The maximum increase in galectin-3 was observed in patients with severe liver fibrosis (F 3). The connection between the level of galectin-3 and the metabolic syndrome components such as body mass index, and insulin resistance was found.https://journal.niidi.ru/jofin/article/view/484chronic hepatitis cgalectin-3liver fibrosisinsulin resistancemetabolic syndrome
spellingShingle V. A. Kovalevа
N. S. Zhevnerova
T. V. Antonova
The level of galectin-3 in the blood serum of patients with chronic hepatitis C
Журнал инфектологии
chronic hepatitis c
galectin-3
liver fibrosis
insulin resistance
metabolic syndrome
title The level of galectin-3 in the blood serum of patients with chronic hepatitis C
title_full The level of galectin-3 in the blood serum of patients with chronic hepatitis C
title_fullStr The level of galectin-3 in the blood serum of patients with chronic hepatitis C
title_full_unstemmed The level of galectin-3 in the blood serum of patients with chronic hepatitis C
title_short The level of galectin-3 in the blood serum of patients with chronic hepatitis C
title_sort level of galectin 3 in the blood serum of patients with chronic hepatitis c
topic chronic hepatitis c
galectin-3
liver fibrosis
insulin resistance
metabolic syndrome
url https://journal.niidi.ru/jofin/article/view/484
work_keys_str_mv AT vakovaleva thelevelofgalectin3inthebloodserumofpatientswithchronichepatitisc
AT nszhevnerova thelevelofgalectin3inthebloodserumofpatientswithchronichepatitisc
AT tvantonova thelevelofgalectin3inthebloodserumofpatientswithchronichepatitisc
AT vakovaleva levelofgalectin3inthebloodserumofpatientswithchronichepatitisc
AT nszhevnerova levelofgalectin3inthebloodserumofpatientswithchronichepatitisc
AT tvantonova levelofgalectin3inthebloodserumofpatientswithchronichepatitisc